BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9392337)

  • 1. Pleomorphic xanthoastrocytoma: DNA flow cytometry and outcome analysis of 12 patients.
    Rostomily RC; Hoyt JW; Berger MS; Kros JM; Alvord EC; Wilkins P; Rabinovitch P
    Cancer; 1997 Dec; 80(11):2141-50. PubMed ID: 9392337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant progression in pleomorphic xanthoastrocytoma: personal experience and review of the literature.
    Marton E; Feletti A; Orvieto E; Longatti P
    J Neurol Sci; 2007 Jan; 252(2):144-53. PubMed ID: 17189643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleomorphic xanthoastrocytoma: what do we really know about it?
    Giannini C; Scheithauer BW; Burger PC; Brat DJ; Wollan PC; Lach B; O'Neill BP
    Cancer; 1999 May; 85(9):2033-45. PubMed ID: 10223246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleomorphic xanthoastrocytoma in children and adolescents.
    Rao AA; Laack NN; Giannini C; Wetmore C
    Pediatr Blood Cancer; 2010 Aug; 55(2):290-4. PubMed ID: 20582976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
    Struikmans H; Rutgers DH; Jansen GH; Tulleken CA; van der Tweel I; Battermann JJ
    Radiat Oncol Investig; 1997; 5(4):170-9. PubMed ID: 9327496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic alterations in pleomorphic xanthoastrocytoma.
    Paulus W; Lisle DK; Tonn JC; Wolf HK; Roggendorf W; Reeves SA; Louis DN
    Acta Neuropathol; 1996; 91(3):293-7. PubMed ID: 8834542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of anaplastic pleomorphic xanthoastrocytoma presenting with tumor bleeding and cerebrospinal fluid dissemination.
    Asano K; Miyamoto S; Kubo O; Kikkukawa T; Yagihashi A; Ohkuma H
    Brain Tumor Pathol; 2006 Apr; 23(1):55-63. PubMed ID: 18095120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior.
    Brown HM; Komorowski RA; Wilson SD; Demeure MJ; Zhu YR
    Cancer; 1999 Oct; 86(8):1583-9. PubMed ID: 10526289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebellar pleomorphic xanthoastrocytoma: case report and literature review.
    Hamlat A; Le Strat A; Guegan Y; Ben-Hassel M; Saikali S
    Surg Neurol; 2007 Jul; 68(1):89-94; discussion 94-5. PubMed ID: 17537486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pleomorphic xanthoastrocytoma].
    Vajtai I; Varga Z
    Orv Hetil; 1997 Apr; 138(16):991-7. PubMed ID: 9190551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the CD34 antigen in pleomorphic xanthoastrocytomas.
    Reifenberger G; Kaulich K; Wiestler OD; Blümcke I
    Acta Neuropathol; 2003 Apr; 105(4):358-64. PubMed ID: 12624789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow-cytophotometry of nuclear DNA in biopsies of 45 human gliomas and after primary culture in vitro.
    Spaar FW; Ahyai A; Spaar U; Gazsó L; Zimmermann A
    Clin Neuropathol; 1986; 5(4):157-75. PubMed ID: 3757347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head and neck paragangliomas: a clinicopathologic study with DNA flow cytometric analysis.
    Granger JK; Houn HY
    South Med J; 1990 Dec; 83(12):1407-12. PubMed ID: 2251529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleomorphic xanthoastrocytoma: a comparative pathological study between conventional and anaplastic types.
    Hirose T; Ishizawa K; Sugiyama K; Kageji T; Ueki K; Kannuki S
    Histopathology; 2008 Jan; 52(2):183-93. PubMed ID: 18184267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleomorphic xanthoastrocytoma: case report and analysis of the literature concerning the efficacy of resection and the significance of necrosis.
    Pahapill PA; Ramsay DA; Del Maestro RF
    Neurosurgery; 1996 Apr; 38(4):822-8; discussion 828-9. PubMed ID: 8692406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subependymal giant cell astrocytoma: a clinical, pathological, and flow cytometric study.
    Shepherd CW; Scheithauer BW; Gomez MR; Altermatt HJ; Katzmann JA
    Neurosurgery; 1991 Jun; 28(6):864-8. PubMed ID: 2067610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of a Promoter Mutation in TERT in Malignant Transformation of Pleomorphic Xanthoastrocytoma.
    Hosono J; Nitta M; Masui K; Maruyama T; Komori T; Yokoo H; Saito T; Muragaki Y; Kawamata T
    World Neurosurg; 2019 Jun; 126():624-630. PubMed ID: 30599247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological features of gliomas in children.
    Hirato J; Nakazato Y
    Noshuyo Byori; 1996 Apr; 13(1):37-47. PubMed ID: 8916125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant transformation of pleomorphic xanthoastrocytoma.
    Nakajima T; Kumabe T; Shamoto H; Watanabe M; Suzuki H; Tominaga T
    Acta Neurochir (Wien); 2006 Jan; 148(1):67-71; discussion 71. PubMed ID: 15912255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.